Johnson & Johnson will buy cardiovascular technology company Abiomed in $16.6 billion deal

News Summary

  • NEW YORK (AP) — Johnson & Johnson will buy cardiovascular technology company Abiomed in $16.6 billion deal.
Elon Musk tweeted a link to an unfounded rumor about the attack on House Speaker Nancy Pelosis husband, just days after Musks purchase of Twitter fueled concerns that the social media platform would [+511 chars]